Regulations Flashcards
1st U.S. Regulation
Kefauver-Harris Drug amendments to the Federal Food, Drug, & Cosmetics Act of 1962, gave the FDA authority
Requires safety & effectiveness evidence for drugs from well-controlled studies & an ICF
2 important goals of ICFH E6 Standards
-assure trial data are credible
-assure the rights, well-being, and confidentiality of trial subject are protected
3 Principles of the Belmont Report and their purpose
Beneficence
Justice
Respect for Persons
Provide basic ethical principals, and boundaries between practice and research
4 Categories of ICH Guidelines
Quality Guidelines
Safety Guidelines
Efficacy Guidelines
Multidisciplinary Guidelines
6 Founding Members of ICH (regulatory & industry)
Current Additonal ICH Members
Observers Regulatory Members
EU, Japan, US, EPPIA (EU), JPMA (Japan), PHRMA (US)
Canada and Swissmedic
Brazil, China, South Korea, WHO
Belmont Report came out of:
National Research Act of 1974 which crated the National Commission for Protection of Human Subjects of Biomedical & Behavioral Research
Beneficence
- Do no harm
- helping or benefiting the patients according to best judgement
- assessment of risks and benefits
- when is it justifiable to seek certain benefits given the risks
- Minimize possible harms, maximize possible benefits
- Risks of distress and embarrassment included
Foundation of Current Ethics
Code of Research Ethics in 1979 from The Belmont Report
Born of Tuskegee
The National Commission for the Protection of Human Subjects of Biomedical and Behavior Research
Commission for the Belmont Report
Identify basic ethical principles that underlie the conduct of human subject research & develop guidelines to assure research is conduct in accordant with those principles
Differences between ICH GCP & DOH
ICH Does not Address:
-Use of placebo vs standard therapy
-Post study access to treatment and other benefits for subjects
-Public disclosure of study design
-Publication of study results
-Disclosure of COIs
For an ICH Protocol-what should be included?
- Title
- Identifiying #
- Date of Trial Design
- Name of sponsor
- Overall investigator
- Labs involved
- Investigational Product-stopping rules, eligibility criteria, monitoring
- Findings from non-clinical studies-efficacy, safety assessments
- Known risks & benefits
- # of subjects
- Administration, dose, route, time of treatment
- Statement of Compliance
- Statistics
- Population
- Literature Background
- Regulatory authority access/ethics
- Objectives & Purpose
- Financing
- Supplements
- Publication
- Endpoints
Formation of ICH
1st Name Change
Revised E6
-Let to creation of standardized guidelines for clinical research of investigational drugs in the early 1990s
October 2015
2016-R1 & R2
2025-R3
GCP
- Good Clinical Practice for ICH
- Sets the Standard for the design, conduct, monitoring & reporting of clinical research
- How human subjects are protected & data is accurate & credible
Henry Beecher
Willowbrook
Jewish Chronic Disease Hospital
1966-22 studies with risks without subjects kowledge
1956-1970-children with intellectual disbilities infected with hepatitis
163-live cancer cells injected into 22 cognitively impaired patients
ICH
- International Council for Harmonisation (2015)
- Previously the International Conference on Harmonisation (90s)
- Standarized guidelines for clinical research of investigational drugs
- Safety, quality, efficacy, and reducation of redundant testing
ICH Progress Reports
written to sponsor & IRB for signifcant changes to the study or increased risks to subjects
-written summary to IRB at least annual unless IRB says sooner
ICH in regards to FDA
ICH is only guidance, not law or regulations in the U.S.
ICH:
Monitoring
Audit
Inspection
- Overseeing progress of trial & ensuring it was conducted, reported, & recorded with the protocol and regulations, ongoing process
- Systematic & independent examination of trial-related activities & documents & data, to ensure tiral followed teh reugaltions, quality assurance, SOPS, and monitoring
- Regulatory authorities official review of documents, facilities, and records related to the tiral, protection of subjects & verify the marketing of data
Justice
- No individual population is exposed to risks while others receive the benefits
- Who should receive the benefits and who should bear the burdens of reserach?
- Can’t choose a population because of convienence
- Benefits and burdens need to be equitably distributed
- No prejudice of creation against a group
- Group chosen should be relevant to the problem being studied
National Research Act
1974, estabilished the National Commission for the protection of human subjects of biomedica & behavioral research, which included the Belmont report, informed consent, requirements for children, establish IRBs
Published in 1977
Nuremberg Code Year
1947
OHRP
Office of Human Research Protections (only federally-funded research)
-oversees IRBs
OHRP created the
International Compilation of Human Research Standards
Principles of Bioethics-Beauchamp & Childress
autonomy, non-maleficence (do no harm), beneficience, & justice